While, in the peripheral blood of patients with immune-mediated disease, Th17 cells are the most critical source of IL-17, in the joints of RA patients, mast cells have been considered essential producers of this interleukin [36]. This evidence concerns the gene IL17A and rheumatoid arthritis.